Table 1. Demographic & Clinical characteristics of 127 patients for HCC and ICC task.
| Demographic and clinical characteristics | Total | HCC/ICC | P value |
|---|---|---|---|
| Number of patients | 127 | 76/51 | – |
| Age (years), median (range) | 55±28 | 54±28/61±25 | 0.211 |
| Gender | 0.194 | ||
| Male | 79 | 58/21 | |
| Female | 33 | 11/22 | |
| AFP (ng/mL) | 0.029 | ||
| ≥20 | 39 | 37/2 | |
| <20 | 73 | 33/40 | |
| CA19-9 (U/mL) | 0.802 | ||
| ≤37 | 74 | 52/22 | |
| >37 | 38 | 18/20 | |
| Tumor size (mm) | 0.001 | ||
| 3 | 21 | 16/5 | |
| 5 | 34 | 23/11 | |
| 10 | 38 | 17/21 | |
| >10 | 21 | 14/7 | |
| Tumor stage | 0.001 | ||
| A | 33 | 25/8 | |
| B | 46 | 32/14 | |
| C | 33 | 13/20 | |
| Tumor amount | 0.112 | ||
| Multiple | 12 | 10/2 | |
| Single | 100 | 60/40 | |
| Satellite node | 0.154 | ||
| None | 81 | 44/37 | |
| 1–3 | 41 | 26/15 |
AFP, alpha-fetoprotein; CA19-9, carbohydrate antigen 19-9; HCC, hepatocellular carcinoma; ICC, intrahepatic cholangiocarcinoma.